Innovis Asset Management LLC Trevi Therapeutics, Inc. Transaction History

Innovis Asset Management LLC

  • $260 Billion
  • Q3 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 03, 2023
SELL
$1.8 - $3.44 $79,446 - $151,831
-44,137 Reduced 50.52%
43,232 $103 Million
Q1 2023

May 10, 2023
SELL
$1.69 - $2.97 $141 - $249
-84 Reduced 0.1%
87,369 $162 Million
Q4 2022

Feb 14, 2023
BUY
$1.61 - $2.42 $140,799 - $211,636
87,453 New
87,453 $169 Million

Others Institutions Holding TRVI

# of Institutions
94
Shares Held
57.1M
Call Options Held
136K
Put Options Held
5.4K
View Full List

About Trevi Therapeutics, Inc.

TRVI Quotes by TradingView
  • Ticker TRVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,322,500
  • Market Cap $162M
  • Description
  • Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of Haduvio to treat serious neurologically mediated conditions. The company is developing Haduvio, an oral extended-release formulation of nalbuphine, which is in phase IIb/III clinical trial for the treatment of chronic pruritu...
More about TRVI
Track This Portfolio

Track Innovis Asset Management LLC Portfolio

Follow Innovis Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Innovis Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Innovis Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email